. The NAD-dependent deacetyThe molecular function of p53 that is required for tumor lase activity of Sir2 is essential for its functions, and this suppression involves its ability to act as a transcriptional activity also connects its biological role with cellular factor in regulating downstream target gene expression metabolism in yeast (Guarente, 2000) . Recently, mam-(reviewed in Nakano and Vousden, 2001; Yu et al., 2001) . malian Sir2 homologs have been found to also contain p53 is a short-lived protein whose activity is mainthe NAD-dependent histone deacetylase activity (Imai tained at low levels in normal cells. Tight regulation of et al., 2000; Smith et al., 2000) , further supporting that p53 is essential for its effect on tumorigenesis as well the enzymatic activity is key to elucidate the molecular as maintaining normal cell growth. The precise mechamechanism for its mediated functions. Among Sir2 and nism by which p53 is activated by cellular stress is not its homolog proteins (HSTs) in yeast, Sir2 is the only completely understood; it is generally thought to involve protein exclusively localized in nuclei, whose activity is mainly posttranslational modifications of p53, including critical for both gene silencing and extension of yeast phosphorylation and acetylation (reviewed in Appella life span (reviewed in Guarente, 2000) . Based on protein sequence homology analysis, mouse Sir2␣ and its human ortholog SIRT1 (or human Sir2␣) are the closest homologs to yeast Sir2 (Imai et al., Frye, 1999 Frye, , 2000 . Both of them exhibit nuclear localization (S.I. and L.G. unpublished data; also in Figure 6C ), but their biological functions remain unclear. Since homologs of Sir2 have been identified in almost all organisms examined including bacteria, which has no histone proteins (reviewed in Guarente, 2000; Frye, 1999 Frye, , 2000 , it is likely that Sir2 also targets nonhistone proteins for functional regulation. Our preliminary results uncovered an activity in protein fractions from mammalian nuclear extract that could effectively deacetylate p53 in the presence of TSA. In support of the possibility that mammalian Sir2␣ targets p53 for functional regulation, we present evidence that mouse Sir2␣ as well as human SIRT1 can directly bind p53 both in vitro and in vivo, and promotes cell survival under stress by specifically repressing p53-dependent apoptotic response. This discovery has important implications for elucidating a biological role for Sir2␣ in mammalian cells.
Results

Mammalian Sir2␣ Interacts with p53 Both In Vitro and In Vivo
Since mouse Sir2␣ shares a highly conserved region at the C terminus with human SIRT1 ( Figure 1A ), but not with any other mammalian Sir2 homologs (Frye, 1999 (Frye, , 2000 , we developed a polyclonal antibody against the C terminus (amino acid 480-737) of mouse Sir2␣. By Western blot analysis, this antibody can detect both mouse Sir2␣ and human SIRT1 proteins, but not other human Sir2 homologs (J.L. and W.G., unpublished data, In order to test whether p53 could be specifically deacetbound to the central DNA binding domain (GST-p53M), ylated by mammalian Sir2␣ in vitro, the mouse Sir2␣ but showed no binding to the N-terminal domain of p53 protein was expressed with the N-terminal Flag epitope (GST-p53NT) (lane 3 versus 2, Figure 1E ). Thus, the in cells and purified to near homogeneity on the M2-above findings demonstrate that p53 interacts with agarose affinity column (lane 3, Figure 2A ). As shown in Figure 2B , 14 C-labeled acetylated p53 was efficiently mammalian Sir2␣ both in vitro and in vivo.
To establish the role for mammalian Sir2␣ in deacetylating p53 in cells, we used an acetylated p53-specific antibody to monitor the steady-state levels of acetylated p53 in vivo (Luo et al., 2000) . As indicated in Figure 2C , a high level of acetylated p53 was found in the cells cotransfected with p300 and p53 (lane 1); however, p53 acetylation levels were significantly abolished by expression of either Sir2␣ or hSIRT1 (lanes 2, 4). In contrast, a point mutation at the highly conserved histidine residue at the core domain (Sir2␣-355A and hSIRT1-363Y) effectively abolished the deacetylase activity (lane 3 versus 2, lane 5 versus 4, Figure 2C ). Furthermore, neither SIRT5, another human Sir2 homolog, nor poly (ADP-ribose) polymerase (PARP), whose activity is also NAD-dependent (reviewed in Vaziri et al., 1997), had any significant effect on p53 acetylation (lanes 6,7, Figure  2C ). In addition, in contrast to HDAC-mediated deacetylation of p53 (Luo et al., 2000) , Sir2␣ still strongly deacetylated p53 in the presence of TSA (lane 4 versus 3, Figure  2D ) even though the steady state level of acetylated p53 was elevated when the cells were treated with TSA (lane 3 versus 1, Figure 2D ). Taken together, these data implicate a strong TSA-independent p53 deacetylation activity of mammalian Sir2␣.
Inhibition of Sir2␣-Mediated p53 Deacetylation by Nicotinamide
To further elucidate the in vivo effect by endogenous We first examined the protein levels of p53 activation . Therefore, the enhancement of results in deacetylation of endogenous p53. Notably, this Sir2␣-mediated effect was completely abrogated the acetylation level of p53 by TSA during DNA damage response may be due mainly to its inhibitory effect on by nicotinamide treatment (lane 8 versus 6, Figure 3C ). Thus, these data indicate that Sir2␣-mediated deacetyendogenous HDAC1-mediated deacetylase activity (lane 3 versus 2, Figure 3D ). Since no significant p53 acetylation lation of p53 can be inhibited by nicotinamide both in vitro and in vivo.
was detected in the cells treated with a proteasome inhibitor ALLN (lane 6, Figure 3D ), indicating that the observed stimulation of p53 acetylation is induced by Maximum Induction of p53 Acetylation Levels in Normal Cells Requires Inhibition DNA damage, not through p53 stabilization. Strikingly, a super induction of p53 acetylation was evident when of Endogenous Sir2␣ Activity After we found that nicotinamide has a strong inhibitory the cells were treated with both TSA and nicotinamide (lane 4 versus 3, Figure 3D ). In contrast, 3-AB treatment effect on Sir2␣-mediated deacetylation in vivo ( Figure  3C ), we further tested whether the endogenous Sir2␣ is had no effect on the level of p53 acetylation (lane 5 versus 3, Figure 3D ), indicating that PARP-mediated critical in regulating the p53 acetylation levels in normal cells during the DNA damage response. As indicated in poly-ADP ribosylation has no effect on p53 acetylation. Figures 4C  and 4D ). These data suggest that mammalian Sir2␣ spedamage treatment by etoposide, the cells were stained Figure 7B ). We further tested whether mammalian Sir2␣ in regulating p53-mediated apoptosis.
hSIRT1-363Y expression has any effect on p53 target genes induced by DNA damage. As indicated in Figure  7C , both p21 and Bax were induced in the cells after DNA Expression of a Sir2␣ Point Mutant Increases damage; interestingly however, the expression levels of the Sensitivity of Cells in the Stress Response both p21 and Bax in hSIRT1-363Y infected cells were To further demonstrate that endogenous Sir2␣ regulates significantly higher than those in mock-infected cells, endogenous p53 under normal conditions, we introindicated that hSIRT1-363Y expression abrogates the duced a Sir2␣ point mutant (hSIRT1-363Y), which is endogenous Sir2␣-mediated repression on p53-depenfunctional-defective in p53 deacetylation ( Figure 2C Figure 7E ). In contrast, pressed a significant amount of the mutant protein hSIRT1-363Y expression led to the cells very sensitive whereas similar levels of p53 were induced in both types to such a mild treatment (50 M H 2 O 2 ); less than 30% of cells after DNA damage treatment (lanes 3, 4 versus of the cells were able to survive after the treatment lanes 1, 2, Figure 7A) . Significantly, the levels of acet-(IV versus III, Figure 7E ). In order to corraborate these ylated p53 were strongly enhanced in the pBaberesults, we also test whether hSIRT1-363Y expression hSIRT1-363Y infected cells, indicating that hSIRT1-363Y functions as a dominant negative mutant and inhibits increases the sensitivity of the cells in DNA damage-induced cell death. As shown in Figure 7D , the pBabethese phosphorylation events contribute to p53 stabilization and activation by preventing the binding with hSIRT1- 
